TA-316
TA-3166 (Megakaryocytes/platelets inducing agent) is a novel chemically synthesized c-MPL agonist (CMA) and thrombopoietin (TPO) receptor agonist. TA-316 enhances ex vivo platelet generation from human-induced pluripotent stem (iPS) cells[1][2].
Product Specifications
CAS Number
1429321-13-0
Product Name Alternative
Megakaryocytes/platelets inducing agent
UNSPSC
12352005
Hazard Statement
H303, H315, H319, H335
Target
Cyclin G-associated Kinase (GAK)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Megakaryocytes-platelets_inducing_agent.html
Purity
99.50
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=C(C(NCC2=CC=C(C(NCCO)=O)C=C2)=O)S1)N/N=C(C3=CSC(C4=CC=C(Br)C=C4)=C3O)\C
Molecular Formula
C28H25BrN4O5S2
Molecular Weight
641.56
Precautions
H303, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD1a / HTA1 (Mature Langerhans Cells Marker) (C1A/1506R), CF594 conjugate, 0.1mg/mL
Tropomyosin 2 (TPM2) (NM_213674) Human Recombinant Protein
